Nephrology Dialysis Transplantation · 2009 · 26 citations · 22 references
MedicineImmunologyPathologyKidney TransplantationRenal PathologyTransplant ImmunologyAcute RejectionAllograft RejectionGraft RejectionRenal ImmunopathologyRenal InflammationTransplant RejectionAcute Vascular RejectionClinical Outcome MeasurementHumoral Immunity ImpairmentHumoral RejectionImmune-mediated Vascular InjuryImmunologic Response To AllograftRecipient Graft SurvivalRenal Transplant Rejection
BACKGROUND: Several studies indicate that interstitial and intracapillary monocytes/macrophages (MO) represent a significant proportion of graft-infiltrating cells in renal allografts and that their presence may unfavourably affect clinical outcome. Much less is known about the role of MO in vascular rejection of transplanted kidneys. The aim of our study was to determine the cellular composition of immune cell infiltrates in intimal arteritis and to analyse whether it is associated with features of humoral immunity and impaired graft survival. METHODS: In 34 recipients with vascular rejection, we determined the proportion of intimal and interstitial MO and T-cells (expressed as ratio of CD68- and CD3-positive cells) in immunohistochemically double-labelled slides. RESULTS: Intimal arteritis is always composed of T-cells and MO with a median CD68/CD3 ratio of 1.03. In 47% of cases, however, T-cells predominate (CD68/CD3 ratio <1). The median interstitial CD68/CD3 ratio is 0.61, with T-cells dominating in 64% of cases. There is no correlation between the cellular composition of arterial and interstitial infiltrates. The proportion of interstitial and arterial MO has no impact on graft survival, and is, in contrast to previous reports on MO in allograft glomerulitis and capillaritis, not associated with C4d staining. CONCLUSIONS: Intimal arteritis in kidney allograft rejection is composed of a mixed infiltrate of MO and T-lymphocytes. In contrast to MO in PTCitis and glomerulitis, the MO in intimal arteritis are not associated with markers of humoral immune response and there are no different allograft outcomes between MO and T-lymphocyte-dominated groups.
22
The Banff 97 working classification of renal allograft pathology
Lorraine C. Racusen, Kim Solez, Robert B. Colvin et al. · Kidney International · 1999 · 3.1K citations
Medicine, Nephrology, Pathology +17
Infiltrates in Protocol Biopsies from Renal Allografts
Michael Mengel, Wilfried Gwinner, Anke Schwarz et al. · American Journal of Transplantation · 2007 · 192 citations
Medicine, Nephrology, Pathology +14